Pei Shu
Impact in
- Immunology top 5%
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 14
- Cancer Immunotherapy and Biomarkers 7
- CAR-T cell therapy research 5
- Cancer Risks and Factors 2
-
- Endometrial and Cervical Cancer Treatments 4
- Co-authors
- Yongsheng Wang (10 shared papers)Qizhi Ma (6 shared papers)Benxia Zhang (5 shared papers)Kai Li (2 shared papers)Yue Chen (1 shared paper)Houhui Shi (1 shared paper)Dan Li (1 shared paper)Xuejin Ou (1 shared paper)
- Journals
- Signal Transduction and Targeted Therapy (3 papers)Frontiers in Immunology (2 papers)Frontiers in Oncology (2 papers)Cancer Management and Research (2 papers)Journal of Hematology & Oncology (1 paper)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Pei Shu
34 papers receiving 2.0k citations
Pei Shu's Hit Papers
Peers
Comparison fields: 5 of 90
- Immunology 573
- Oncology 530
- Endocrine and Autonomic Systems 126
- Genetics 317
- Cancer Research 142
Countries citing papers authored by Pei Shu
This map shows the geographic impact of Pei Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pei Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pei Shu more than expected).
Fields of papers citing papers by Pei Shu
This network shows the impact of papers produced by Pei Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pei Shu. The network helps show where Pei Shu may publish in the future.
Co-authors
The 25 scholars most cited alongside Pei Shu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer Hit paper breakdown → | 2021 | 739 |
| 2 | 1997 | 338 | |
| 3 | 1996 | 311 | |
| 4 | 1999 | 149 | |
| 5 | 2002 | 76 | |
| 6 | 1997 | 72 | |
| 7 | 2015 | 50 | |
| 8 | 2020 | 44 | |
| 9 | 2022 | 44 | |
| 10 | 2019 | 39 | |
| 11 | 2024 | 35 | |
| 12 | 2023 | 25 | |
| 13 | 2023 | 25 | |
| 14 | 2008 | 15 | |
| 15 | 2020 | 7 | |
| 16 | 2021 | 7 | |
| 17 | 2025 | 7 | |
| 18 | 2020 | 6 | |
| 19 | 2015 | 5 | |
| 20 | 2023 | 5 |
About Pei Shu
Pei Shu is a scholar working on Oncology, Obstetrics and Gynecology, Immunology, Pulmonary and Respiratory Medicine and Surgery, having authored 40 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (5 papers), Endometrial and Cervical Cancer Treatments (4 papers), Lung Cancer Treatments and Mutations (4 papers), Immune Cell Function and Interaction (3 papers), Cervical Cancer and HPV Research (2 papers), Cancer Risks and Factors (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Immunology (573 citations), Oncology (530 citations), Endocrine and Autonomic Systems (126 citations), Genetics (317 citations) and Cancer Research (142 citations). Pei Shu has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Yongsheng Wang, Qizhi Ma, Benxia Zhang, Kai Li, Yue Chen, Houhui Shi, Dan Li, Xuejin Ou, Karen J. Moore and John S. Smutko. Their work appears in journals such as Signal Transduction and Targeted Therapy, Frontiers in Immunology, Frontiers in Oncology, Cancer Management and Research and Journal of Hematology & Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.